Cas:64768-38-3 ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 manufacturer & supplier

We serve Chemical Name:ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 CAS:64768-38-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3

Chemical Name:ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3
CAS.NO:64768-38-3
Synonyms:ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3
Molecular Formula:C6H5BrD6O2
Molecular Weight:201.09100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.30000
Exact Mass:200.03200
LogP:1.72300

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 Use and application,ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 technical grade,usp/ep/jp grade.


Related News: From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 manufacturer The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 supplier From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 vendor In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” ethyl 2-bromo-2-methyl-d3-propionate-3,3,3-d3 factory Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it.